Stock Detail
HELICOS BIOSCIENCES CORPORATION
Drugs - Generic
HLCS @ Yahoo Finance | HLCS Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $0.13 | $0.14 | $0.00 | 0.00% | 0.00 | $0.14 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $0.00 | $0.13 | 93,230 | 0 | 0 | -1.18 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 0.14 | 0.13 | 0.13 | 0.12 | 0.12 |
Stock Profile
Helicos BioSciences Corporation, a life sciences company, engages in the development of genetic analysis technologies for the research, drug discovery, and clinical diagnostics markets. The company is incorporating its proprietary True Single Molecule Sequencing technology into its commercial product consisting of an instrument called the HeliScope and its associated reagents and supplies. It intends to offer the HeliScope, which is used to enable ultra-high-throughput genetic analysis based on the direct sequencing of single molecules of DNA or single copies of RNA. The company intends to sell its system in North America, Europe, and Asia. Helicos BioSciences Corporation was founded in 2003 and is headquartered in Cambridge, Massachusetts.